(Cure Lab, Inc.) Protective or therapeutic vaccines hit to be supplemented with adjuvants, brawny facilitators of the insusceptible response. A essay publicised today in the book Vaccine by the Colony supported biotech consort Cure Lab, Inc., describes a new intra-molecular adjuvant. This adjuvant is a “protein tail” essential in neurodegenerative Huntington’s disease, that allows antigenic proteins to self-assemble into nano-size particles that safely alter both branches of the insusceptible system.